6 DECEMBER 2024LIFE SCIENCES REVIEWThe European regulatory landscape is undergoing a transformative shift, integrating advanced technologies and sustainability to foster innovation and competitiveness. Key trends such as the EU Banking Package are redefining compliance frameworks by emphasising environmental, social and governance (ESG) priorities. These measures strengthen governance, enhance transparency and drive sustainability across industries, enabling firms to navigate an ESG-focused market effectively.Artificial intelligence (AI) and machine learning are playing pivotal roles in this transformation. By automating compliance monitoring and streamlining complex processes, these technologies ensure greater efficiency and accuracy. AI systems proactively detect risks, predict regulatory changes, and reduce manual burdens, allowing organisations to stay ahead in an evolving compliance landscape. Regulatory bodies are also leveraging AI to enhance decision-making, fostering a more agile and adaptive regulatory environment.Driven by these trends, the regulatory services industry is expected to grow steadily over the forecast period, recording a CAGR of 15.3 percent between 2024-2029. This edition of the Life Sciences Review Europe offers a deeper insight into the recent advancements in regulatory services and how companies are adapting to the latest technologies to effectively benefit clients across most industries. It features a thought leadership article from Dr. Linda Randall, Associate Vice President, Biologics Development, Manufacturing and Control at Pharmaron, emphasising the major manufacturing trends impacting gene therapy. Additionally, it also features an article from Line Sandberg, Chief Quality Officer, Centrient Pharmaceuticals, shedding light on the importance of matters like process thinking and working on enhancing compliance through process leadership. We also bring you the story of Regulatory Services Company of the Year in Europe 2024, which is at the forefront of transformative regulated industries. A prominent story is that of Dada Consultancy. This well-established brand offers a complete range of high-quality, tailored regulatory and pharmacovigilance services for human and veterinary products.In this edition of Life Sciences Review Europe for the year 2024, we hope you come across the right partner that perfectly caters to your organisational requirements.Let us know what you think!EDITORIALAI, ESG and Strategic Autonomy: The Future of European Regulatory ServicesCopyright © 2024 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com DECEMBER - 11 - 2024, Vol 05, Issue - 55 (ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizerDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsRobert Grey SmithClara Matthew
< Page 5 | Page 7 >